Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
John McConnell, S. Pinar Bilir, Yifan Xu, Yuen Tsang & Sumeet Panjabi. (2023) Hospitalization-related costs associated with oral agents targeting the prostacyclin pathway for pulmonary arterial hypertension. Journal of Medical Economics 26:1, pages 1349-1355.
Read now
Read now
Manreet K. Kanwar, Michele Cole, Marjolaine Gauthier-Loiselle, Ameur M. Manceur, Yuen Tsang, Patrick Lefebvre, Sumeet Panjabi & Raymond L. Benza. (2021) Development and validation of a claims-based model to identify patients at risk of chronic thromboembolic pulmonary hypertension following acute pulmonary embolism. Current Medical Research and Opinion 37:9, pages 1483-1491.
Read now
Read now
Rahul G Argula, Celine Ward & Carol Feghali-Bostwick. (2019) Therapeutic Challenges And Advances In The Management Of Systemic Sclerosis-Related Pulmonary Arterial Hypertension (SSc-PAH). Therapeutics and Clinical Risk Management 15, pages 1427-1442.
Read now
Read now
Victoria Delgado. (2017) Right Ventricular Dyssynchrony to Measure the Effects of Pulmonary Endarterectomy in Chronic Thromboembolic Pulmonary Hypertension. Structural Heart 1:3-4, pages 160-161.
Read now
Read now
Peter Norman. (2015) Evaluation of WO-2014132220, selective PDGFR inhibitors for the treatment of pulmonary arterial hypertension. Expert Opinion on Therapeutic Patents 25:4, pages 493-499.
Read now
Read now
Peter Norman. (2014) Pulmonary arterial hypertension: a rare disease that encourages the development of multiple treatments. Expert Opinion on Orphan Drugs 2:11, pages 1137-1145.
Read now
Read now
Samuel Johnson, Thomas Delate, Adrian Boka, Paul Shaw & Carol Zager. (2013) Characterizing the financial burden of pulmonary arterial hypertension within an integrated healthcare delivery system. Journal of Medical Economics 16:12, pages 1414-1422.
Read now
Read now
Ronda Copher, Annamaria Cerulli, Angela Watkins & Maria Laura Monsalvo. (2012) Treatment patterns and healthcare system burden of managed care patients with suspected pulmonary arterial hypertension in the United States. Journal of Medical Economics 15:5, pages 947-955.
Read now
Read now
Jason M. Ali, Gillian Hardman, Aravinda Page & David P. Jenkins. (2012) Chronic Thromboembolic Pulmonary Hypertension: An Underdiagnosed Entity?. Hospital Practice 40:3, pages 71-79.
Read now
Read now
Articles from other publishers (39)
Vallerie McLaughlin, Adnan Alsumali, Rongzhe Liu, Rogier Klok, Eliana C. Martinez, Iman Nourhussein, David Bernotas, Jestinah Chevure, Christine Pausch, Janethe De Oliveira Pena, Dominik Lautsch & Marius M. Hoeper. (2023) Population Health Model Predicting the Long-Term Impact of Sotatercept on Morbidity and Mortality in Patients with Pulmonary Arterial Hypertension (PAH). Advances in Therapy.
Crossref
Crossref
Charles D BurgerBenjamin WuPeter ClassiKellie Morland. (2023) Inhaled treprostinil vs iloprost: Comparison of adherence, persistence, and health care resource utilization in patients with pulmonary arterial hypertension. Journal of Managed Care & Specialty Pharmacy 29:1, pages 101-108.
Crossref
Crossref
Eva‐Maria Didden, Eileen Lee, Julie Wyckmans, Deborah Quinn & Loïc Perchenet. (2023) Time to diagnosis of pulmonary hypertension and diagnostic burden: A retrospective analysis of nationwide US healthcare data. Pulmonary Circulation 13:1.
Crossref
Crossref
Adesuwa OgbomoYuen TsangRajesh MallampatiSumeet Panjabi. (2022) The direct and indirect health care costs associated with pulmonary arterial hypertension among commercially insured patients in the United States. Journal of Managed Care & Specialty Pharmacy 28:6, pages 608-616.
Crossref
Crossref
Yu Zhang, Moises Hernandez, Jonathan GowerNolan Winicki, Xena Morataya, Sebastian Alvarez, Jason X.-J. Yuan, John ShyyPatricia A. Thistlethwaite. (2022) JAGGED-NOTCH3 signaling in vascular remodeling in pulmonary arterial hypertension. Science Translational Medicine 14:643.
Crossref
Crossref
Helen Christou & Raouf A. Khalil. (2022) Mechanisms of pulmonary vascular dysfunction in pulmonary hypertension and implications for novel therapies. American Journal of Physiology-Heart and Circulatory Physiology 322:5, pages H702-H724.
Crossref
Crossref
Linh Ho, Nazir Hossen, Trieu Nguyen, Au Vo & Fakhrul Ahsan. (2022) Epigenetic Mechanisms as Emerging Therapeutic Targets and Microfluidic Chips Application in Pulmonary Arterial Hypertension. Biomedicines 10:1, pages 170.
Crossref
Crossref
Sophia Emmons‐Bell, Catherine Johnson, Alexandra Boon‐Dooley, Paul A. Corris, Peter J. Leary, Stuart Rich, Magdi Yacoub & Gregory A. Roth. (2022) Prevalence, incidence, and survival of pulmonary arterial hypertension: A systematic review for the global burden of disease 2020 study. Pulmonary Circulation 12:1.
Crossref
Crossref
Hossein-Ardeschir Ghofrani, Andrea M. D'Armini, Nick H. Kim, Eckhard Mayer & Gérald Simonneau. (2021) Interventional and pharmacological management of chronic thromboembolic pulmonary hypertension. Respiratory Medicine 177, pages 106293.
Crossref
Crossref
Laurence Leber, Amélie Beaudet & Audrey Muller. (2021) Epidemiology of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: identification of the most accurate estimates from a systematic literature review. Pulmonary Circulation 11:1, pages 1-12.
Crossref
Crossref
Jessica Y. HsuJennifer L. MajorAndrew S. RichingRwik SenJulie Pires da SilvaRushita A. Bagchi. (2020) Beyond the genome: challenges and potential for epigenetics-driven therapeutic approaches in pulmonary arterial hypertension. Biochemistry and Cell Biology 98:6, pages 631-646.
Crossref
Crossref
Jason K. Bowman, Sayon Dutta, Hui Zheng, Cassie Kraus & Susan R. Wilcox. (2020) Patients with pulmonary hypertension presenting to the emergency department. The American Journal of Emergency Medicine 38:11, pages 2313-2317.
Crossref
Crossref
Viviane P. Sprecher, Eva‐Maria Didden, Joel N. Swerdel & Audrey Muller. (2020) Evaluation of code‐based algorithms to identify pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension patients in large administrative databases. Pulmonary Circulation 10:4, pages 1-10.
Crossref
Crossref
Scott A. Helgeson, Divya Menon, Haytham Helmi, Charitha Vadlamudi, John E. Moss, Tonya K. Zeiger & Charles D. Burger. (2020) Psychosocial and Financial Burden of Therapy in USA Patients with Pulmonary Arterial Hypertension. Diseases 8:2, pages 22.
Crossref
Crossref
Simon Lannou, Nicolas Mansencal, Cécile Couchoud, Mathilde Lassalle, Olivier Dubourg, Bénédicte Stengel, Christian Jacquelinet & Philippe Charron. (2020) The Public Health Burden of Cardiomyopathies: Insights from a Nationwide Inpatient Study. Journal of Clinical Medicine 9:4, pages 920.
Crossref
Crossref
Biswajit Chowdhury, Albert Z. Luu, Vincent Z. Luu, M. Golam Kabir, Yi Pan, Hwee Teoh, Adrian Quan, Sandra Sabongui, Mohammed Al-Omran, Deepak L. Bhatt, C. David Mazer, Kim A. Connelly, Subodh Verma & David A. Hess. (2020) The SGLT2 inhibitor empagliflozin reduces mortality and prevents progression in experimental pulmonary hypertension. Biochemical and Biophysical Research Communications 524:1, pages 50-56.
Crossref
Crossref
Kathleen M. Mortimer, Dorothee B. Bartels, Nadine Hartmann, Jorge Capapey, Jing Yang, Robert Gately & Cheryl Enger. (2020) Characterizing Health Outcomes in Idiopathic Pulmonary Fibrosis using US Health Claims Data. Respiration 99:2, pages 108-118.
Crossref
Crossref
Kathleen Mortimer, Nadine Hartmann, Christine Chan, Heather Norman, Laura Wallace & Cheryl Enger. (2019) Characterizing idiopathic pulmonary fibrosis patients using US Medicare-advantage health plan claims data. BMC Pulmonary Medicine 19:1.
Crossref
Crossref
Kelly Stam, Zongye Cai, Nikki van der Velde, Richard van Duin, Esther Lam, Jolanda van der Velden, Alexander Hirsch, Dirk J Duncker & Daphne Merkus. (2019)
Cardiac remodelling in a swine model of chronic thromboembolic pulmonary hypertension: comparison of right
vs
. left ventricle
. The Journal of Physiology 597:17, pages 4465-4480.
Crossref
Crossref
Stephen C. Mathai, Anna Ryan Hemnes, Scott Manaker, Rebekah H. Anguiano, Bonnie B. Dean, Vishal Saundankar, Peter Classi, Andrew C. Nelsen, Kathryn Gordon & Corey E. Ventetuolo. (2019) Identifying Patients with Pulmonary Arterial Hypertension Using Administrative Claims Algorithms. Annals of the American Thoracic Society 16:7, pages 797-806.
Crossref
Crossref
V. Cottin, D. Avot, L. Lévy-Bachelot, C. A. Baxter, D. R. Ramey, L. Catella, S. Bénard, O. Sitbon & S. Teal. (2019) Identifying chronic thromboembolic pulmonary hypertension through the French national hospital discharge database. PLOS ONE 14:4, pages e0214649.
Crossref
Crossref
Kari R. Gillmeyer, Ming-Ming Lee, Alissa P. Link, Elizabeth S. Klings, Seppo T. Rinne & Renda Soylemez Wiener. (2019) Accuracy of Algorithms to Identify Pulmonary Arterial Hypertension in Administrative Data. Chest 155:4, pages 680-688.
Crossref
Crossref
S. V. Shalaev, M. V. Arkhipov, A. L. Iofin, A. N. Bykov, L. V. Evrgafova, O. E. Yakovleva, D. F. Nizamova, V. A. Balina & E. V. Milovanova. (2019) EXPERIENCE OF IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION PATIENTS MANAGEMENT IN URAL FEDERAL DISTRICT: FEATURES OFOUTPATIENT-HOSPITAL INTERACTIONS. Eurasian heart journal:1, pages 14-28.
Crossref
Crossref
A. N. BykovM. V. Arkhipov, N. F. KlimushevaA. I. Iofin. (2018) LEFT MAIN CORONARY ARTERY COMPRESSION SYNDROME IN PATIENT WITH PULMONARY ARTERIAL HYPERTENSION. FIRST CLINICAL EXPERIENCE. Eurasian heart journal:4, pages 98-117.
Crossref
Crossref
Stephen C. Mathai & Sherin Mathew. (2018) Breathing (and Coding?) a Bit Easier. Chest 154:1, pages 207-218.
Crossref
Crossref
Chris L. ScelsiWilliam B. BatesYulia V. MelenevskyGyanendra K. SharmaNorman B. ThomsonJayanth H. Keshavamurthy. (2018) Egg-and-Banana Sign: A Novel Diagnostic CT Marker for Pulmonary Hypertension. American Journal of Roentgenology 210:6, pages 1235-1239.
Crossref
Crossref
Ravikanth Papani, Gulshan Sharma, Amitesh Agarwal, Sean J. Callahan, Winston J. Chan, Yong‐Fang Kuo, Yun M. Shim, Andrew D. Mihalek & Alexander G. Duarte. (2018) Validation of claims‐based algorithms for pulmonary arterial hypertension. Pulmonary Circulation 8:2, pages 1-8.
Crossref
Crossref
Aileen Kharat, Anne-Lise Hachulla, Stéphane Noble & Frédéric Lador. (2018) Modern diagnosis of chronic thromboembolic pulmonary hypertension. Thrombosis Research 163, pages 260-265.
Crossref
Crossref
Elena Pfeuffer, Holger Krannich, Michael Halank, Heinrike Wilkens, Philipp Kolb, Berthold Jany & Matthias Held. (2017) Anxiety, Depression, and Health-Related QOL in Patients Diagnosed with PAH or CTEPH. Lung 195:6, pages 759-768.
Crossref
Crossref
Christine DiversDavid PlattEdward WangJay LinMelissa Lingohr-SmithStephen C. Mathai. (2017) A Review of Clinical Trial Endpoints of Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension and How They Relate to Patient Outcomes in the United States. Journal of Managed Care & Specialty Pharmacy 23:1, pages 92-104.
Crossref
Crossref
Justin A. Edward & Stacy Mandras. (2017) An Update on the Management of Chronic Thromboembolic Pulmonary Hypertension. Current Problems in Cardiology 42:1, pages 7-38.
Crossref
Crossref
Paul D. Stein. 2016. Pulmonary Embolism. Pulmonary Embolism
634
638
.
Paul D. Stein, Fadi Matta & Patrick G. Hughes. (2015) Scope of Problem of Pulmonary Arterial Hypertension. The American Journal of Medicine 128:8, pages 844-851.
Crossref
Crossref
Tiago Machuca & Marc de Perrot. (2015) When to Refer a Patient With Chronic Thromboembolic Pulmonary Hypertension for Pulmonary Endarterectomy. Canadian Journal of Cardiology 31:4, pages 509-514.
Crossref
Crossref
Mirko Sikirica, Serban R Iorga, Tim Bancroft & Jesse Potash. (2014) The economic burden of pulmonary arterial hypertension (PAH) in the US on payers and patients. BMC Health Services Research 14:1.
Crossref
Crossref
Lodovico Balducci. 2014. Hemostasis and Thrombosis. Hemostasis and Thrombosis
259
270
.
Nick H. Kim, Marion Delcroix, David P. Jenkins, Richard Channick, Philippe Dartevelle, Pavel Jansa, Irene Lang, Michael M. Madani, Hitoshi Ogino, Vittorio Pengo & Eckhard Mayer. (2013) Chronic Thromboembolic Pulmonary Hypertension. Journal of the American College of Cardiology 62:25, pages D92-D99.
Crossref
Crossref
Aravinda Page, Jason M Ali, Jane Maraka, Robert Mackenzie-Ross & David P Jenkins. (2013) Management of chronic thromboembolic pulmonary hypertension: current status and emerging options. Clinical Practice 10:3, pages 345-357.
Crossref
Crossref
Nicola Bonner, Linda Abetz, Juliette Meunier, Mirko Sikirica & Stephen C Mathai. (2013) Development and validation of the living with pulmonary hypertension questionnaire in pulmonary arterial hypertension patients. Health and Quality of Life Outcomes 11:1, pages 161.
Crossref
Crossref